Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents

被引:48
作者
Glueck, CJ [1 ]
Morrison, JA
Friedman, LA
Goldenberg, N
Stroop, DM
Wang, P
机构
[1] Alliance Hosp, Cholesterol Ctr, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA
[3] Childrens Hosp, Med Ctr, Div Cardiol, Cincinnati, OH 45229 USA
[4] Maryland Med Res Inst, Baltimore, MD USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2006年 / 55卷 / 04期
关键词
D O I
10.1016/j.metabol.2005.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adolescent girls with polycystic ovary syndrome (PCOS) have increased levels of factors constituting the metabolic syndrome: centripetal obesity, hypertension, hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-C), and hyperinsulinemia. Given the strong association reported between early, persistent obesity and development of metabolic syndrome 10 years later in girls, we speculated that if adolescent girls without PCOS had obesity measures similar to girls with PCOS, they would exhibit similar metabolic syndrome-cardiovascular disease risk factors. Within this context, we compared 37 adolescent girls with PCOS and 2 samples of normal, regularly cycling adolescent girls (controls) of similar ages, selected from the Cincinnati Clinic of the National Heart, Lung, and Blood Institute Growth and Health Study. The first sample included 157 controls selected using a stratified random sample based on age. As expected, girls with PCOS had higher body mass index (BMI), waist circumference, insulin, systolic blood pressure (SBP) and diastolic blood pressure, triglycerides (TGs), lower HDL-C, and higher low-density lipoprotein cholesterol (LDL-C) and free testosterone (FT) than controls. A second sample consisted of girls matched one to one with girls with PCOS for BMI and age. Comparisons of group differences were not significant for insulin, lipids, or blood pressure;, girls with PCOS had a trend toward higher values for waist circumference (median, 92.7 vs 87.5 cm; P = .07) and much higher median FT (4.25 vs 1.42 ng/mL, P = .0001). After matching for BMI and age, by conditional regression analysis, we showed that the groups were not differentiated (P > .15) by insulin, HDL-C, LDL-C, TG, SBP, or diastolic blood pressure, but were differentiated by higher FT (P = .0024) and waist circumference (P = .0024) in PCOS than in controls. Prospective longitudinal analyses of NHGS controls showed that changes in BMI from ages 9 to 10 years to ages 15 to 16 years were positively associated with changes in waist circumference (P < .0001), LDL-C (P = .01), TG (P = .008), and SBP (P = .002). These findings suggest that if adolescent girls achieve adiposity equal to girls with PCOS, they then acquire major components of the metabolic syndrome, and excluding high FT and waist circumference, comparable increased cardiovascular disease risk. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:508 / 514
页数:7
相关论文
共 48 条
[1]   Insulin, androgens, and obesity in women with and without polycystic ovary syndrome:: a heterogeneous group of disorders [J].
Acién, P ;
Quereda, F ;
Matallín, P ;
Villarroya, E ;
López-Fernández, JA ;
Acién, M ;
Mauri, M ;
Alfayate, R .
FERTILITY AND STERILITY, 1999, 72 (01) :32-40
[2]   Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].
Buchanan, TA ;
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Tan, S ;
Berkowitz, K ;
Hodis, HN ;
Azen, SP .
DIABETES, 2002, 51 (09) :2796-2803
[3]   Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome [J].
Carr, DB ;
Utzschneider, KM ;
Hull, RL ;
Kodama, K ;
Retzlaff, BM ;
Brunzell, JD ;
Shofer, JB ;
Fish, BE ;
Knopp, RH ;
Kahn, SE .
DIABETES, 2004, 53 (08) :2087-2094
[4]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[5]   The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes [J].
Freemark, M ;
Bursey, D .
PEDIATRICS, 2001, 107 (04) :E55
[6]   Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome [J].
Gambineri, A ;
Pelusi, C ;
Genghini, S ;
Morselli-Labate, AM ;
Cacciari, M ;
Pagotto, U ;
Pasquali, R .
CLINICAL ENDOCRINOLOGY, 2004, 60 (02) :241-249
[7]   Obesity and the polycystic ovary syndrome [J].
Gambineri, A ;
Pelusi, C ;
Vicennati, V ;
Pagotto, U ;
Pasquali, R .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (07) :883-896
[8]   Metformin and gestational diabetes [J].
Charles J. Glueck ;
Naila Goldenberg ;
Patricia Streicher ;
Ping Wang .
Current Diabetes Reports, 2003, 3 (4) :303-312
[9]  
Glueck Charles J, 2002, Expert Opin Pharmacother, V3, P1177
[10]   Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome [J].
Glueck, CJ ;
Wang, P ;
Kobayashi, S ;
Phillips, H ;
Sieve-Smith, L .
FERTILITY AND STERILITY, 2002, 77 (03) :520-525